|
GGTLC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60640000002044E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.84480000007004E-07 |
| Normal-vs-Stage2 |
5.372300E-02 |
| Normal-vs-Stage3 |
7.754200E-04 |
| Normal-vs-Stage4 |
3.760000E-03 |
| Stage1-vs-Stage2 |
2.489700E-02 |
| Stage1-vs-Stage3 |
2.839800E-01 |
| Stage1-vs-Stage4 |
3.407600E-01 |
| Stage2-vs-Stage3 |
2.881400E-01 |
| Stage2-vs-Stage4 |
3.173200E-01 |
| Stage3-vs-Stage4 |
9.739800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.26679999995694E-06 |
| Normal-vs-AfricanAmerican |
1.762390E-03 |
| Normal-vs-Asian |
9.753400E-01 |
| Caucasian-vs-AfricanAmerican |
3.747000E-01 |
| Caucasian-vs-Asian |
1.604290E-02 |
| AfricanAmerican-vs-Asian |
9.097600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.380500E-04 |
| Normal-vs-Female |
6.01789995613444E-09 |
| Male-vs-Female |
2.586900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.524300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.69590000000031E-05 |
| Normal-vs-Age(61-80Yrs) |
7.56929999999878E-05 |
| Normal-vs-Age(81-100Yrs) |
2.571100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.530600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.793600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.513600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.885400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.171800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.581400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.067710E-02 |
| Normal-vs-Grade 2 |
1.58815999999895E-05 |
| Normal-vs-Grade 3 |
2.10979999999417E-05 |
| Normal-vs-Grade 4 |
1.434020E-02 |
| Grade 1-vs-Grade 2 |
2.582400E-01 |
| Grade 1-vs-Grade 3 |
1.642420E-01 |
| Grade 1-vs-Grade 4 |
2.235400E-01 |
| Grade 2-vs-Grade 3 |
7.560600E-01 |
| Grade 2-vs-Grade 4 |
5.442400E-01 |
| Grade 3-vs-Grade 4 |
7.023200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.05679997875319E-09 |
| Normal-vs-ccB subtype |
8.470200E-01 |
| ccA subtype-vs-ccB subtype |
2.38142838782096E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.40369999999968E-05 |
| Normal-vs-N1 |
2.114400E-02 |
| N0-vs-N1 |
9.454200E-01 |
|
|
